Search

everythinglearnresearchcommunity

for

Search:↓

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Alzheimer's may be treated by targeting gut bacteria and inflammation.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

New Australian advertising rules improved stem cell marketing practices but further regulation is needed for consumer safety.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Kinematic alignment in knee surgery often requires smaller femoral components than mechanical alignment.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

The paper concludes that drug labels should be clear for all, especially for those with low literacy, and suggests aiming for high comprehension test passing rates with diverse test populations.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

The article concludes that products can affect the body without being drugs as long as they don't claim to treat or prevent diseases, except for cosmetic sunscreens.

Finasteride use for hair loss is linked to an increased risk of suicidal thoughts and a higher risk of suicide.

Finasteride, a hair loss drug, is linked to increased suicidal thoughts, particularly when used for hair loss.

The conclusion is that finasteride is linked to an increased risk of suicidal thoughts and a higher risk of completed suicide when used for hair loss.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

A new acne cream effectively reduced acne in trials and awaits FDA approval.

Finasteride use may increase suicidality risk, especially in young men.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Robotics will greatly change dentistry with ongoing tech advancements.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.